A bid to stop a trial involving puberty blockers is rejected by the High Court, and recruitment is expected to begin shortly, including participants as young as 11. Campaigners had urged the court to order an immediate halt, arguing that the trial is “deeply unethical and highly dangerous” and that regulators acted unlawfully when approving it. They contended that the approval process did not comply with legal requirements and sought judicial intervention before the study moves forward. After the court’s decision, the focus shifts to the planned timetable for recruitment and the trial’s continued operation under the conditions set by regulators. The available reporting centers on the challenge to the legality of the approval and the court’s refusal to block the trial, rather than the trial’s scientific aims, oversight details, or outcomes. The court’s ruling means the trial proceeds as scheduled unless further legal steps are taken.